Navegar por término MeSH "Camptothecin"

Mostrando ítems 1-3 de 3

A multimarker panel for circulating tumor cells detection predicts patient outcome and therapy response in metastatic colorectal cancer

2014- Barbazán García, Jorge; Muinelo Romay , Laura; Vieito Villar, María; Candamio Folgar, Sonia; Díaz-López, A.; [et al.]
Efficacy and safety of FOLFIRI/aflibercept in second-line treatment of metastatic colorectal cancer in a real-world population: Prognostic and predictive markers

2019- Fernández Montes, Ana; Martinez Lago, Nieves Purificacion; Covela Rúa, Marta; De La Cámara Gómez, Juan Cruz; González Villaroel, Paula; [et al.]
FOLFOXIRI plus bevacizumab versus FOLFOX plus bevacizumab for patients with metastatic colorectal cancer and ?3 circulating tumour cells: the randomised phase III VISNÚ-1 trial

2020- Aranda, Enrique; Viéitez, Jose Maria; Gómez-España, Auxiliadora; Gil Calle, Silvia; Salud-Salvia, Antonieta; [et al.]